Cargando…

C-reactive protein levels and prevalence of leukopenia in patients with inflammatory bowel disease treated with azathioprine and/or mesalazine: a real-life study

OBJECTIVE: To examine serum C-reactive protein levels and the prevalence of leukopenia in patients with Crohn’s disease or ulcerative colitis undergoing treatment with azathioprine and/or mesalazine. METHODS: Retrospective observational study based on clinical and laboratory data collected from medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	dos Santos, Rejani Cristine Faustino, Catapani, Wilson Roberto, Takahashi, André Akira Ramos, Waisberg, Jaques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060644/ https://www.ncbi.nlm.nih.gov/pubmed/35584442 http://dx.doi.org/10.31744/einstein_journal/2022AO6500

Ejemplares similares

Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound
por: Barnhoorn, Marieke C, et al.
Publicado: (2021)

Azathioprine is More Effective than Mesalazine at Preventing Recurrent Bowel Obstruction in Patients with Ileocecal Crohn’s Disease
por: Vidigal, Fernando Mendonça, et al.
Publicado: (2014)

Azathioprine/infliximab/mesalazine: Coronavirus disease-19: case report
Publicado: (2020)

Implementation of NUDT15 Genotyping to Prevent Azathioprine‐Induced Leukopenia for Patients With Autoimmune Disorders in Chinese Population
por: Wang, Chuang‐Wei, et al.
Publicado: (2022)

Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn’s disease patients
por: de Souza, Gláucio Silva, et al.
Publicado: (2013)

NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients
por: Fei, Xiang, et al.
Publicado: (2018)

Combining Clinical and Candidate Gene Data into a Risk Score for Azathioprine-Associated Leukopenia in Routine Clinical Practice
por: Anandi, Prathima, et al.
Publicado: (2020)

Real-World Use of Azathioprine Metabolites Changes Clinical Management of Inflammatory Bowel Disease
por: Wilson, Laura, et al.
Publicado: (2020)

Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome
por: Dorofeyev, Andrey E, et al.
Publicado: (2011)

Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis
por: Zhang, Fen-Ming, et al.
Publicado: (2019)

Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
por: Matsumoto, Satohiro, et al.
Publicado: (2020)

Contrast medium‐induced transient severe leukopenia
por: Hongo, Takashi, et al.
Publicado: (2017)

Azathioprine in inflammatory bowel disease, a safe alternative?
por: Tanis, A A
Publicado: (1998)

Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2013)

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease.
por: Mulder, C J, et al.
Publicado: (1998)

Hypersensitivity to mesalazine in a patient with inflammatory bowel disease: a case report
por: Cronin, Kevin C, et al.
Publicado: (2009)

Leukopenia: Its Relation to Neuralgia
Publicado: (1916)

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
por: Matsuoka, Katsuyoshi
Publicado: (2020)

Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
por: Yewale, Rohan V, et al.
Publicado: (2023)

Primary extensive perianal cutaneous tuberculosis: A challenging diagnosis. Case report and a review of the literature
por: Takahashi, André Akira Ramos, et al.
Publicado: (2022)

Mesalazine-induced renal calculi
por: Jacobsson, Henrik, et al.
Publicado: (2013)

Myocarditis Related to the Use of Mesalazine
por: Kyriakou, Michaela, et al.
Publicado: (2023)

Randomised controlled trial of mesalazine in IBS
por: Barbara, Giovanni, et al.
Publicado: (2016)

Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles
por: Lau, Esther T. L., et al.
Publicado: (2013)

Safety and effectiveness of laparoscopic Y-en-Roux gastric bypass surgery in obese elderly patients
por: dos Santos, Marcelo Protásio, et al.
Publicado: (2020)

Awareness of adverse effects of Azathioprine in patients with Inflammatory Bowel Disease – more to be done?
por: Spence, Andrew David Roy, et al.
Publicado: (2014)

Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
por: van Liere, Elsa L. S. A., et al.
Publicado: (2021)

Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives
por: Stolfi, Carmine, et al.
Publicado: (2012)

Mesalazine-induced myocarditis: a case report
por: Radhakrishnan, Shiva T., et al.
Publicado: (2018)

Repurposing mesalazine against cardiac fibrosis in vitro
por: Hoffmann, Maximilian, et al.
Publicado: (2020)

Mesalazine-induced myopericarditis: a case report
por: Shergill, Simran
Publicado: (2020)

Analysis of clinical characteristics of mesalazine-induced cardiotoxicity
por: Chen, Junyu, et al.
Publicado: (2022)

Nanoparticles Obtained from Zein for Encapsulation of Mesalazine
por: Lima, Izabela Borges C., et al.
Publicado: (2022)

Mesalazine-induced myopericarditis: a case series
por: Andrei, Valentina, et al.
Publicado: (2023)

LEUKOPENIA WITH GRANULOCYTOPENIA IN EXPERIMENTAL MUCORMYCOSIS (RHIZOPUS ORYZAE INFECTION
por: Bauer, Heinz, et al.
Publicado: (1957)

Prognostic significance of leukopenia in childhood acute lymphoblastic leukemia
por: SHIOZAWA, YUSUKE, et al.
Publicado: (2014)

Unexplained chronic leukopenia treated with oral iron supplements
por: Abuirmeileh, Ayman, et al.
Publicado: (2013)

Determination of etiology in patients admitted due to isolated leukopenia
por: Mart, Gulay, et al.
Publicado: (2022)

Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
por: Jorge, B., et al.
Publicado: (2021)

Slowly progressing acute lymphoblastic leukemia with prolonged leukopenia
por: Sugisaki, Manato, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qje16kf1id9hf7k68rif77o4v4